SLA PHARMA (IRE) LIMITED

SLA Pharma (IRE) Limited is a specialised global pharmaceutical company dedicated exclusively to the development of medicines for the prevention and treatment of gastrointestinal and related disorders. Drawing on more than three decades of experience in clinical trials worldwide, the firm combines deep medical, regulatory and commercial expertise to bring targeted therapies to market across digestive health, gastrointestinal oncology and proctology.

The company’s portfolio centres on innovative solutions for a broad range of GI conditions, underpinned by rigorous scientific validation and close collaboration with leading researchers, clinicians and pharmaceutical organisations. This partnership network ensures that every treatment is backed by robust evidence and meets the highest standards of safety and efficacy.

SLA Pharma serves healthcare professionals worldwide, offering them cutting‑edge medicines that address unmet needs in gastrointestinal health. By maintaining a singular focus on this therapeutic area, the company has established itself as a world leader in GI drug development, continually advancing patient care through research‑driven innovation.